Results 51 to 60 of about 8,420 (208)
This study aims to formulate Olmesartan medoxomil (OM) into oral fast-dissolving tablets (FDTs) to improve its solubility and bioavailability via two different techniques; the polymer-based surface solid dispersion (SSD) technique and the solidified ...
Baher A Daihom +5 more
doaj +1 more source
Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen +3 more
wiley +1 more source
Antagonizing the angiotensin II subtype 1 receptor: a focus on olmesartan medoxomil
BACKGROUND: The orally active, nonpeptide antagonists of the angiotensin II subtype 1 (AT1) receptor represent a recent class of antihypertensive drugs that selectively block the renin-angiotensin system. Olmesartan medoxomil is the newest member of this
Koike H +5 more
core +1 more source
Background Nowadays combination therapy has become more popular due to their additional effect, synergistic effect and antagonistic effect. Any of these can influence the treatment profile.
Matrika Saha Roy +8 more
doaj +1 more source
ABSTRACT Introduction Osteoporosis is a chronic skeletal condition that significantly affects daily life and may benefit from adequate self‐care. The Middle‐Range Theory of Self‐Care of Chronic Illness conceptualizes self‐care as a naturalistic process encompassing maintenance, monitoring, and management, also shaped by contextual and cultural factors.
Chiara Tedesco +14 more
wiley +1 more source
The present study is oriented to synthesis of radioiodinated olmesartan medoxomil (OM) for potential cardiac imaging. Olmesartan medoxomil has been labeled with [125/131I] using chloramine-T (Ch-T) as an oxidizing agent. The key effective factors such as
Safaa B. Challan +2 more
core +1 more source
Current hypertension guidelines recommend using two antihypertensive agents when blood pressure (BP) control is not achieved with one single agent. Objective: This study was designed to assess the antihypertensive benefit of the olmesartan medoxomil 40mg/
Melani L +5 more
core +1 more source
Steatocystoma Multiplex Suppurativa—A Case Report and Review of Treatments
ABSTRACT We report a case of Steatocystoma Multiplex Suppurativa (SMS), a rare condition that can mimic hidradenitis suppurativa (HS). We also present a review of the surgical and medical therapies, including potential biologic agents.
Justin Tam Vu, Alexis Daniel Lara Rivero
wiley +1 more source
Stability-indicating comparative methods using mekc and lc for determination of olmesartan medoxomil
A stability-indicating method using MEKC was validated for the analysis of olmesartan medoxomil in tablets. Successful separation was achieved using a fused silica capillary (40 cm x 50 µm i.d.); background electrolyte consisted of a combination of 10 ...
Lisiane Bajerski +8 more
doaj +3 more sources
Sustainability in Analytical Chemistry Illustrated by Pharmaceutical Nitrosamine Testing
ABSTRACT Following the valsartan scandal in 2018, the testing of drug substances and drug products for N‐nitrosamines has become a critical and mandatory quality control measure. The European Pharmacopoeia chapter 2.5.42 currently describes three analytical methods for this purpose: HPLC–MS/MS, GC–MS, and GC–MS/MS.
Felix Bredendiek +2 more
wiley +1 more source

